Category: McKesson Corp.Syndicate content

McKesson dodges Medicare fraud charges

July 11, 2014 by Arezu Sarvestani

A federal judge dismisses a whistleblower lawsuit accusing McKesson of encouraging Medicare fraud and getting rid of workers who opposed the scheme.

McKesson dodges Medicare fraud charges

San Francisco-based healthcare giant McKesson (NYSE:MCK) dodged a Medicare fraud lawsuit this week after a federal judge ruled that prospective whistleblower Leslie Ann Williams didn't have enough evidence to support her accusations.

FDA puts highest-risk label on McKesson's anesthesia system recall

March 18, 2014 by Arezu Sarvestani

McKesson Technologies recalls its anesthesia care system over a potential software glitch that mismatched patient case data with patient data.

Updated March 20, 2014, at 3:15 p.m. with comments from McKesson

White House has missed half of ACA deadlines | On Call

August 20, 2013 by Sony Salzman

The White House has let half of the Affordable Care Act's mandatory deadlines slip by, according to a report by the non-partisan Congressional Research Service.

MassDevice On Call

MASSDEVICE ON CALL — During the 1st 3 years of Affordable Care Act implementation, the Obama administration has failed to meet half of its mandatory deadlines, according to a new report from the non-partisan Congressional Research Service.

Study: Abbott, Johnson & Johnson park billions in offshore tax havens

August 5, 2013 by Brad Perriello

Abbott and Johnson & Johnson are among the U.S.-based companies that park billions in offshore tax havens, according to a U.S. PIRG report.

Study: Abbott, Johnson & Johnson park billions in offshore tax havens

Abbott (NYSE:ABT) parked some $40 billion in 107 overseas tax havens last year, making it 1 of the top 15 U.S. companies with the most money held offshore, according to a U.S. Public Interest Research Group report issued last month.

McKesson to pay $2B for PSS World Medical | Wall Street Beat

October 25, 2012 by MassDevice staff

McKesson agrees to pony up more than $2 billion for medical supplies provider PSS World Medical. Wall Street Beat

McKesson (NYSE:MCK) agreed to pay $29 per share for PSS World Medical (NSDQ:PSSI) and its medical supplies business in a deal worth $2.1 billion.

Abiomed: Medicare coverage decision unlikely for Impella | Wall Street Beat

September 26, 2012 by MassDevice staff

Medical device company Abiomed says the chances are slim that Medicare will grant a national coverage decision for its Impella heart pump. Wall Street Beat

Abiomed (NSDQ:ABMD) said it doesn't believe that the Centers for Medicare & Medicaid Services is likely to bestow a national coverage decision for its Impella heart pump.

Supreme Court denies ex-McKesson CEO's appeal

June 19, 2012 by MassDevice staff

Former McKesson Corp. chairman & CEO Charles McCall fails to pass muster with the U.S. Supreme Court, which rejected his bid for an appeal to reconsider his 10-year prison sentence tied to a conviction for an accounting scandal.

healthcare law

The Supreme Court refused to review the conviction of former McKesson (NYSE:MCK) chairman & CEO Charles McCall in an accounting scandal, meaning his 10-year prison sentence will stand.

The high court provided no comment on the denial. San Francisco, Calif.-based McKesson is the largest drug distributor in the U.S., and also deals in healthcare information technology products.